Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 30, 2019

SELL
$44.62 - $49.34 $35,339 - $39,077
-792 Closed
0 $0
Q1 2019

Jun 12, 2019

SELL
$45.12 - $53.8 $7,083 - $8,446
-157 Reduced 16.54%
792 $1.61 Million
Q4 2018

Jun 12, 2019

BUY
$48.76 - $63.23 $46,273 - $60,005
949 New
949 $49,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First National Corp Portfolio

Follow First National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

News

Stay updated on First National Corp with notifications on news.